A patent law change pushed by the pharmaceutical industry could cost federal health-care programs $1.3 billion over a decade by delaying new generic drugs, the Congressional Budget Office estimates.
from WSJ.com: US Business http://ift.tt/1NJyBwE
via IFTTT
No comments:
Post a Comment